Skip to main content

Advertisement

Log in

A case of Degos disease: demonstration of C5b-9-mediated vascular injury

  • Case Report
  • Published:
Modern Rheumatology

Abstract

A 68-year-old Japanese male presented with atrophic erythematous white lesions with peripheral dark reddish rims on his back. Multiple ulcers were detected from his stomach to his large intestine using endoscopy. Although the patient was given high doses of a steroid, aspirin, dipyridamole, and intravenous immunoglobulin therapy, he died of gastrointestinal hemorrhage, perforation and septic shock. An autopsy examination revealed pauci-inflammatory thrombotic microangiopathy with endothelial cell injury, fibrous occlusive arteriopathy, and vascular C5b-9 deposition in the wall of the gastrointestinal tract from the esophagus to the large intestine as well as in the dermis of the skin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Beljaards RC, Starink TM, Meuwissen SG. 2 families with malignant atrophic papulosis (Degos disease) (in Dutch). Ned Tijdschr Geneeskd. 1988;132:269–71.

    PubMed  CAS  Google Scholar 

  2. Durie BG, Stroud JD, Kahn JA. Progressive systemic sclerosis with malignant atrophic papulosis. Arch Dermatol. 1969;100:575–81.

    Article  PubMed  CAS  Google Scholar 

  3. Fernandez-Flores A, Manjon JA, Mencia J. Diabetes mellitus and Degos disease (published correction appears in Bratisl Lek Listy. 2008;109:533). Bratisl Lek Listy. 2008;109:414–7.

    PubMed  CAS  Google Scholar 

  4. Snow JL, Muller SA. Degos syndrome: malignant atrophic papulosis. Semin Dermatol. 1995;14:99–105.

    Article  PubMed  CAS  Google Scholar 

  5. Doutre MS, Beylot C, Bioulac P, et al. Skin lesions resembling malignant atrophic papulosis in lupus erythematosus. Dermatologica. 1987;175:45–6.

    Article  PubMed  CAS  Google Scholar 

  6. Notash AY, Mazoochy H, Mirshams M, et al. Lethal systemic Degos disease with prominent cardio-pulmonary involvement. Saudi Med J. 2008;29:133–7.

    PubMed  Google Scholar 

  7. High WA, Aranda J, Patel SB, et al. Is Degos’ disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol. 2004;50:895–9.

    Article  PubMed  Google Scholar 

  8. Megro CM, Poe JC, Kim C et al. Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol. 2011;135:599–610.

    Google Scholar 

  9. Tsao H, Busam K, Barnhill RL, et al. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol. 1997;36:317–9.

    Article  PubMed  CAS  Google Scholar 

  10. Heymann WR. Degos disease: considerations for reclassification. J Am Acad Dermatol. 2009;61(3):505–06.

    Google Scholar 

  11. Kolb WP, Muller-Eberhard HJ. Neoantigens of the membrane attack complex of complement. Proc Natl Acad Sci USA. 1975;72:1687–9.

    Article  PubMed  CAS  Google Scholar 

  12. Kinoshita T. Biology of complement: the overture. Immunol Today. 1991;12:202–5.

    Article  Google Scholar 

  13. Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol. 1985;85(1 suppl):165S–75S.

    Article  PubMed  CAS  Google Scholar 

  14. Norris DA, Ryan SB, Kissinger RM, Fritz KA, Boyce ST. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro. J Immunol. 1985;135:1073–9.

    PubMed  CAS  Google Scholar 

  15. Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993;100:58S–68S.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusuke Miwa.

About this article

Cite this article

Umemura, M., Miwa, Y., Yanai, R. et al. A case of Degos disease: demonstration of C5b-9-mediated vascular injury. Mod Rheumatol (2013). https://doi.org/10.1007/s10165-013-0888-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10165-013-0888-x

Keywords

Navigation